Cite

HARVARD Citation

    Kotecki, N. et al. (2019). Adjuvant therapeutic approaches of HER2-positive breast cancer with a focus on neratinib maleate. Expert review of anticancer therapy. 19 (6), pp. 447-454. [Online]. 
  
Back to record